BY SEAN WHOOLEY

The Mobi-C cervical disc.

ZimVie (Nasdaq: ZIMV)+ announced today that the first U.S. patient received its new 4.5mm Mobi-C cervical disc.

Mobi-C became the first cervical disc approved for one and two levels by the FDA in 2013. Ten years later, in August of this year, ZimVie picked up FDA approval for a smaller height for the device. The updated 4.5mm Mobi-C comes in seven footprints to match patient anatomy.
Dr. Gregory D. Lopez of Midwest Orthopaedics at Rush in Chicago implanted the first of these devices in the U.S. on Oct. 30.
“The 59-year-old patient presented with a significantly collapsed C5-6 disc, and the new lower profile Mobi-C implant allowed me to avoid over-distracting the facet joints,” Lopez said in a news release. “The 4.5mm height Mobi-C makes it possible for me to offer pain relief and motion preservation to more of my patients with cervical disc degeneration.”
Mobi-C, a cobalt chromium alloy and polyethylene mobile-bearing prosthesis, features a single-step implantation process. ZimVie says implantation takes place through an anterior approach.
It eliminates the need for bone chiseling or other vertebral anchorage like screws or keels. The implant treats skeletally mature patients to reconstruct the disc from C3 to C7 following discectomy.
“It is an honor to celebrate the first U.S. implantation of the 4.5mm Mobi-C Cervical Disc. ZimVie is dedicated to bringing the right products to the market, and it really hits home to know that patients are benefiting from our efforts,” said Rebecca Whitney, global president of ZimVie Spine.